Fuller & Thaler Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Fuller & Thaler Asset Management's GILD Position: Q3 2017 in Review
Fuller & Thaler Asset Management sold out of Gilead Sciences (GILD) in Q3 2017, closing a stake of 13,100 shares — an estimated $927K sold.
Fuller & Thaler Asset Management first reported a position in GILD in Q2 2013 and held it in 17 quarters. The position peaked at $2.14M in Q3 2014. 1,503 funds tracked by Wall St. Rank hold GILD as of Q3 2017.
- Fuller & Thaler Asset Management reported no remaining Gilead Sciences position as of Q3 2017 after selling out during the quarter.
- Fuller & Thaler Asset Management sold 13,100 Gilead Sciences shares in Q3 2017, an estimated $927K.
- Fuller & Thaler Asset Management first reported a position in Gilead Sciences in Q2 2013 and held it in 17 quarters.
- Fuller & Thaler Asset Management's Gilead Sciences position peaked at $2.14M in Q3 2014.
- 1,503 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2017.
Based on Fuller & Thaler Asset Management's 13F filing for Q3 2017, filed 8 Nov 2017.